BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results